PT Kimia Farma Tbk (ISX:KAEF) Other Financing: Rp52,472 Mil (TTM As of Mar. 2026)


ISX:KAEF PT Kimia Farma Tbk ISX:KAEF
51 GF Score
Price Rp454.00
GF Value Rp581.54
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Kimia Farma Tbk Other Financing?

PT Kimia Farma Tbk ISX:KAEF +0.89% 51 Other Financing is Rp52,472 Mil as of Mar. 2026. GuruFocus rates ISX:KAEF with a GF Score™ of 51/100 and a GF Value™ of Rp581.54 (Modestly Undervalued). The stock has 4 warning signs investors should review.

PT Kimia Farma Tbk's Other Financing for the three months ended in Mar. 2026 was Rp116,724 Mil.

PT Kimia Farma Tbk's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was Rp52,472 Mil.

PT Kimia Farma Tbk Other Financing Historical Data

* Premium members only.

The historical data trend for PT Kimia Farma Tbk's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Kimia Farma Tbk Other Financing Chart

PT Kimia Farma Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10,472.59 1,390,556.21 -64,862.48 -61,392.53 -44,552.95

PT Kimia Farma Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.73 135.35 -18,543.00 -45,844.64 116,724.10
ISX:KAEF
51GF Score
PT Kimia Farma Tbk ISX:KAEF
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Kimia Farma Tbk Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp52,472 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of Rp52,472 Mil mean?
PT Kimia Farma Tbk (ISX:KAEF) has a Other Financing of Rp52,472 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for PT Kimia Farma Tbk and its competitors.
Is PT Kimia Farma Tbk's Other Financing too high?
PT Kimia Farma Tbk's current Other Financing is Rp52,472 Mil. Overall, PT Kimia Farma Tbk has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kimia Farma Tbk's Other Financing compare to MCK and CAH?
PT Kimia Farma Tbk's Other Financing of Rp52,472 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Distribution company?
A good Other Financing depends on the Medical Distribution industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for PT Kimia Farma Tbk and its competitors. PT Kimia Farma Tbk's current Other Financing is Rp52,472 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kimia Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kimia Farma Tbk (ISX:KAEF) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp581.54, compared to a current price of Rp454.00 — trading 21.9% below its estimated fair value. The current Other Financing is Rp52,472 Mil. PT Kimia Farma Tbk's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For PT Kimia Farma Tbk (ISX:KAEF), the current Other Financing is Rp52,472 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Kimia Farma Tbk (ISX:KAEF) Overvalued in 2026?

Based on GuruFocus' analysis, PT Kimia Farma Tbk stock appears to be undervalued. The current stock price of Rp454.00 is trading 21.9% below its estimated GF Value™ of Rp581.54. GuruFocus considers PT Kimia Farma Tbk to be Modestly Undervalued.

Key valuation signals for ISX:KAEF:

  • Other Financing: Rp52,472 Mil
  • GF Value™: Rp581.54 vs. price of Rp454.00 (21.9% below fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Kimia Farma Tbk Business Description

Address Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
51GF Score

Get the complete analysis for ISX:KAEF

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp454.00
Price
Rp581.54
GF Value